The University of Southampton
University of Southampton Institutional Repository

A diversity of SERCA Ca2+ pump inhibitors

A diversity of SERCA Ca2+ pump inhibitors
A diversity of SERCA Ca2+ pump inhibitors
The SERCA (sarcoplasmic/endoplasmic reticulum Ca2+-ATPase) is probably the most extensively studied membrane protein transporter. There is a vast array of diverse inhibitors for the Ca2+ pump, and many have proved significant in helping to elucidate both the mechanism of transport and gaining conformational structures. Some SERCA inhibitors such as thapsigargin have been used extensively as pharmacological tools to probe the roles of Ca2+ stores in Ca2+ signalling processes. Furthermore, some inhibitors have been implicated in the cause of diseases associated with endocrine disruption by environmental pollutants, whereas others are being developed as potential anticancer agents. The present review therefore aims to highlight some of the wide range of chemically diverse inhibitors that are known, their mechanisms of action and their binding location on the Ca2+ ATPase. Additionally, some ideas for the future development of more useful isoform-specific inhibitors and anticancer drugs are presented.
0300-5127
789-797
Michelangeli, Francesco
7faf285c-9365-4f87-96c5-ab68070bb50b
East, J.Malcolm
9fe7f794-1d89-4935-9a99-b831d786056e
Michelangeli, Francesco
7faf285c-9365-4f87-96c5-ab68070bb50b
East, J.Malcolm
9fe7f794-1d89-4935-9a99-b831d786056e

Michelangeli, Francesco and East, J.Malcolm (2011) A diversity of SERCA Ca2+ pump inhibitors. Biochemical Society Transactions, 39 (3), 789-797. (doi:10.1042/BST0390789). (PMID:21599650)

Record type: Article

Abstract

The SERCA (sarcoplasmic/endoplasmic reticulum Ca2+-ATPase) is probably the most extensively studied membrane protein transporter. There is a vast array of diverse inhibitors for the Ca2+ pump, and many have proved significant in helping to elucidate both the mechanism of transport and gaining conformational structures. Some SERCA inhibitors such as thapsigargin have been used extensively as pharmacological tools to probe the roles of Ca2+ stores in Ca2+ signalling processes. Furthermore, some inhibitors have been implicated in the cause of diseases associated with endocrine disruption by environmental pollutants, whereas others are being developed as potential anticancer agents. The present review therefore aims to highlight some of the wide range of chemically diverse inhibitors that are known, their mechanisms of action and their binding location on the Ca2+ ATPase. Additionally, some ideas for the future development of more useful isoform-specific inhibitors and anticancer drugs are presented.

This record has no associated files available for download.

More information

Published date: June 2011
Organisations: Molecular and Cellular

Identifiers

Local EPrints ID: 208179
URI: http://eprints.soton.ac.uk/id/eprint/208179
ISSN: 0300-5127
PURE UUID: 26586f3d-3af3-4658-81bd-2e13e1604591

Catalogue record

Date deposited: 18 Jan 2012 12:31
Last modified: 14 Mar 2024 04:41

Export record

Altmetrics

Contributors

Author: Francesco Michelangeli
Author: J.Malcolm East

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×